Specialty Drug Pipeline Reviews to help you
Control Medical Drug Spend

Sign up for RJ Health Drug Alerts below to access our collection of reviews.

If you are already a Drug Alerts subscriber, simply re-enter your email to be redirected.

Our current collection of specialty drug pipeline reviews available to Drug Alerts subscribers includes:

Rituxan (Rituximab) Biosimilars

Original FDA Approval: November 26, 1997
Last Updated: December 7, 2017

Burosumab-twza (Crysvita®)

Orginal FDA Approval: April 17, 2018
Last updated: March 14, 2018

Cemiplimab-rwlc (Libtayo®)

Original FDA Approval: September 28, 2018
Last Updated: October 15, 2018

Erenumab-aooe (Aimovig™)

Original FDA Approval: May 17, 2018
Last Updated: March 9, 2018

Fremanezumab-vfrm (Ajovy™)

Original FDA Approval: September 14, 2018
Last Updated: September 24, 2018

Ibalizumab-uiyk (Trogarzo™)

Original FDA Approval: March 6, 2018
Last Updated: March 6, 2018

Inotersen sodium (Tegsedi™)

Original FDA Approval: October 5, 2018
Last Updated: October 16, 2018

Lanadelumab-flyo (Takhzyro™)

Original FDA Approval: August 23, 2018
Last Updated: August 27, 2018

Mogamulizumab-kpkc (Poteligeo®)

Original FDA Approval: August 8, 2018
Last Updated: August 10, 2018

Moxetumomab pasudotox-tdfk (Lumoxiti™)

Original FDA Approval: September 13, 2018
Last Updated: September 21, 2018

Patisiran (Onpattro™)

Original FDA Approval: August 10, 2018
Last Updated: August 13, 2018

Pegfilgrastim-cbqv (Udenyca™)

Original FDA Approval: November 2, 2018
Last Updated: November 5, 2018

Tildrakizumab-asmn (Ilumya™)

Original FDA Approval: March 20, 2018
Last Updated: February 28, 2018

Volanesorsen (Waylivra)

Phase 3 Clinical Development: Sept 25, 1998
Last Updated: July 25, 2018

Venetoclax (Venclexta ®)

Original FDA Approval: April 11, 2016
Last Updated: January 17, 2019

Sacituzumab Govitecan

Complete Response Letter: January 17, 2019
Last Updated: January 17, 2019

Calaspoagase Pegol-mknl (Asparlas™)

Original FDA Approval: December 20, 2018
Last Updated: February, 4 2019

Ravulizumab-cwvz (Ultomiris™)

Original FDA Approval: December 21, 2018
Last Updated: February, 4 2019

Tagraxofusp-erzs (Elzonris™)

Original FDA Approval: December 21, 2018
Last Updated: February, 4 2019

Nivolumab + Ipilimumab (Opdivo® + Yervoy®)

Original FDA Approval: September 30, 2015
Last Updated: February 11, 2019

Pembrolizumab (Keytruda®)

Original FDA Approval: September 4, 2014
Last Updated: February 20, 2019

Caplacizumab (Cablivi™)

Original FDA Approval: February 6, 2018
Last Updated: February 20, 2019

Tipiracil hydrochloride + Trifluridine (Lonsurf®)

Original FDA Approval: September 22, 2015
Last Updated: February 28, 2019

Olaparib (Lynparza®)

Original FDA Approval: December 12, 2014
Last Updated: February 29, 2019

RI-002 (ADMA Biologics)

PDUFA: April 2, 2019
Last Updated: March 4, 2019

Selinexor

PDUFA: July 6, 2019
Last Updated: March 18, 2019

Trastuzumab (Herceptin®) Biosimilars

Original FDA Approval: September 25, 1998
Last Updated: February 26, 2018

Ruxolitinib phosphate (Jakafi®)

Original FDA Approval: November 6, 2011
Last Updated: March 18, 2019

Atezolizumab (Tecentriq®)

Original FDA Approval: May 18, 2016
Last Updated: March 20, 2019

Siponimod (Mayzent®)

Original FDA Approval: March 26, 2019
Last Updated: March 26, 2019

Evenity™ (Romosozumab-aqqg)

Original FDA Approval: April 9, 2019
Last Updated: April 9, 2019